146 related articles for article (PubMed ID: 24199708)
21. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
[TBL] [Abstract][Full Text] [Related]
22. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
Nat Commun; 2013; 4():1551. PubMed ID: 23462994
[TBL] [Abstract][Full Text] [Related]
23. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.
Schmitt CA; McCurrach ME; de Stanchina E; Wallace-Brodeur RR; Lowe SW
Genes Dev; 1999 Oct; 13(20):2670-7. PubMed ID: 10541553
[TBL] [Abstract][Full Text] [Related]
24. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
25. Regulated expression of the ubiquitin protein ligase, E3(Histone)/LASU1/Mule/ARF-BP1/HUWE1, during spermatogenesis.
Liu Z; Miao D; Xia Q; Hermo L; Wing SS
Dev Dyn; 2007 Oct; 236(10):2889-98. PubMed ID: 17823942
[TBL] [Abstract][Full Text] [Related]
26. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2.
Yu K; Ravera CP; Chen YN; McMahon G
Cell Growth Differ; 1997 Jul; 8(7):731-42. PubMed ID: 9218867
[TBL] [Abstract][Full Text] [Related]
28. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
Sugihara E; Shimizu T; Kojima K; Onishi N; Kai K; Ishizawa J; Nagata K; Hashimoto N; Honda H; Kanno M; Miwa M; Okada S; Andreeff M; Saya H
Oncogene; 2012 Jun; 31(23):2849-61. PubMed ID: 21986948
[TBL] [Abstract][Full Text] [Related]
29. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
30. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
31. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.
Rooney S; Sekiguchi J; Whitlow S; Eckersdorff M; Manis JP; Lee C; Ferguson DO; Alt FW
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2410-5. PubMed ID: 14983023
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
33. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M
Genes Dev; 1999 Oct; 13(20):2678-90. PubMed ID: 10541554
[TBL] [Abstract][Full Text] [Related]
34. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
35. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
36. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
Chen D; Kon N; Zhong J; Zhang P; Yu L; Gu W
Mol Cell; 2013 Jul; 51(1):46-56. PubMed ID: 23747016
[TBL] [Abstract][Full Text] [Related]
37. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
[TBL] [Abstract][Full Text] [Related]
38. Life, death, and ubiquitin: taming the mule.
Shmueli A; Oren M
Cell; 2005 Jul; 121(7):963-5. PubMed ID: 15989944
[TBL] [Abstract][Full Text] [Related]
39. Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions.
Wang L; Luk CT; Schroer SA; Smith AM; Li X; Cai EP; Gaisano H; MacDonald PE; Hao Z; Mak TW; Woo M
Diabetologia; 2014 Sep; 57(9):1889-98. PubMed ID: 24981769
[TBL] [Abstract][Full Text] [Related]
40. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
